These Combined Biomarkers Help Identify Melanomas at Low Risk of Metastasis
The combined biomarkers, AMBRA1 and loricrin can be used to reliably stratify stage I and II melanomas at genuine low risk of progression.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
